View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
May 17, 2019updated 23 Dec 2019 10:22am

Microsoft supports development of epilepsy prediction device

US-based technology company Microsoft has awarded an Artificial Intelligence (AI) for Accessibility grant to the University of Sydney in Australia to support the development of an epilepsy prediction device.

US-based technology company Microsoft has awarded an Artificial Intelligence (AI) for Accessibility grant to the University of Sydney in Australia to support the development of an epilepsy prediction device.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

Named NeuroSyd, the device will be designed to act as a seizure warning system via real-time monitoring and processing of brain-signals that indicate an epileptic seizure.

“This research project is designed to provide a greater degree of independence to a specific cohort of individuals living with epilepsy.”

Primarily intended to help adult epilepsy patients while driving, the device will provide an early warning of the possibility of an epileptic seizure strike. This is expected to facilitate measures to potentially avoid consequences that come with an unpredictable seizure.

University of Sydney electrical engineering faculty Dr Omid Kavehei said: “This research project is designed to provide a greater degree of independence to a specific cohort of individuals living with epilepsy, that will help better manage against the seemingly unpredictable nature of seizures.”

For the research project, Microsoft’s AI and machine learning capabilities will be combined with university’s expertise in electronics and biomedical signal processing.

In addition, the university researchers will work with the Royal Price Alfred Hospital and the Cerebral Palsy Alliance of NSW to develop the epilepsy prediction device.

Microsoft Australia accessibility lead David Masters noted: “Using state of the art AI and machine learning and current and historical data on brain activity, the team hopes to create a portable, non-surgical device that can provide someone with up to 30 minutes’ warning about a likely seizure.”

Nearly 65 million people are suffering with epilepsy globally, including around 250,000 individuals in Australia.

The condition could be effectively managed with first or second anti-epileptic drugs in many patients. However, failure of these medicines significantly decreases the chance of responding to further drugs, resulting in drug resistant epilepsy in approximately 30% of patients.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network